Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of uterine corpus leiomyoma characterized by extensive myxoid degeneration of the neoplasm connective tissue stroma.
No clinical trials have been registered for uterine corpus myxoid leiomyoma.
4 publications have been identified in PubMed for uterine corpus myxoid leiomyoma. Research spans Case Report / Case Series (75%) and Review / Meta-Analysis (25%).
Palo S (2025). [PMID: 40625645](https://pubmed.ncbi.nlm.nih.gov/40625645/). *Oncoscience*. [Case Report / Case Series]
Yorita K (2025). [PMID: 40557015](https://pubmed.ncbi.nlm.nih.gov/40557015/). *Cureus*. [Case Report / Case Series]
Ma C (2025). [PMID: 40804412](https://pubmed.ncbi.nlm.nih.gov/40804412/). *Diagn Pathol*. [Review / Meta-Analysis]
Bai L (2024). [PMID: 39372869](https://pubmed.ncbi.nlm.nih.gov/39372869/). *Front Oncol*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC